Back to Authors

Bohbot, Y

Mayo Clinic

Centre Hospitalier Universitaire Amiens-Picardie

Citations 1

Extent and Progression of Cardiac Damage in Patients With Primary Mitral Regurgitation Undergoing Surgical Repair
Myagmardorj, Rinchyenkhand , Fortuni, Federico , Mantegazza, Valentina , Wijngaarden, A.K.S. van, Wu, Hoi Wai , Palmen, Meindert , Pepi, Mauro, Fusini, Laura , Muratori, Manuela , Essayagh, Benjamin , Tribouilloy, Christophe​, Tourneau, Thierry Le, Bohbot, Y, Michelena, Hector I, Bax, Jeroen J, Marsan, Nina Ajmone, Fortuni, Federico , Wijngaarden, Aniek L. van , van Wijngaarden, Aniek , Pepi, Mauro , Tribouilloy, Christophe , Le Tourneau, Thierry , Bohbot, Yohann , Michelena, Hector I , Enriquez-Sarano, Maurice , Bax, Jeroen J , Marsan, Nina Ajmone , Essayagh, Benjamin , Tribouilloy, Christophe , Tourneau, Thierry Le , Bohbot, Yohann , Michelena, Héctor I. , Enriquez‐Sarano, Maurice , Bax, Jeroen J. , Marsan, Nina Ajmone

European Journal of Cardio-Thoracic Surgery | April 9, 2026 | Volume: 68 | Issue: 5 | Pages: No page available

10.1093/ejcts/ezag149 Get It

Abstract Objectives The progression of extra-mitral valve (MV) cardiac damage in patients with primary mitral regurgitation (MR) following surgical repair has not been described. We aimed to investigate the evolution of extra-MV cardiac damage after MV repair and to assess its prognostic significance. Methods Patients with severe primary MR undergoing surgical repair at 5 referral centres were included when echocardiographic follow-up assessment was available. Based on echocardiographic parameters at baseline and at a median follow-up of 7 (interquartile range [IQR] 4-11) months after MV repair, patients were hierarchically classified as follows: stage 0: no cardiac damage; stage 1: left ventricular dilatation and/or dysfunction; stage 2: left atrial dilatation and/or atrial fibrillation; stage 3: pulmonary hypertension and/or significant tricuspid regurgitation. The primary outcome was all-cause mortality. Results A total of 764 patients (mean age 62 ± 13 years, 70% men) were included. Compared to baseline, 43% improved at least 1 stage, 49% remained unchanged, and 8% worsened at least 1 stage during follow-up after MV repair. At a median follow-up of 91 months after MV repair, 94 patients (12%) died. By multivariate Cox regression analysis, after adjusting for potential confounders, extra-MV cardiac damage staging at follow-up (HR per-1-stage-increase = 1.571; P = .009) and cardiac damage evolution (improved group, HR = 0.467; P = .034; worsened group, HR = 2.481, P = .037) were independently associated with all-cause mortality and had incremental prognostic value over preprocedural assessment. Conclusions Extra-MV cardiac damage improves significantly after MV repair, and its evolution is independently associated with all-cause mortality, suggesting the importance of comparative echocardiographic assessment following MV repair to improve risk stratification.